Cart
sales@molnova.com
SKLB-23bb
CAS No. 1815580-06-3
SKLB-23bb ( —— )
Catalog No. M20404 CAS No. 1815580-06-3
SKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 140 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 411 | In Stock |
|
| 25MG | 678 | In Stock |
|
| 50MG | 954 | In Stock |
|
| 100MG | 1287 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSKLB-23bb
-
NoteResearch use only not for human use.
-
Brief DescriptionSKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability.
-
DescriptionSKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1815580-06-3
-
Formula Weight396.44
-
Molecular FormulaC21H24N4O4?
-
Purity>98% (HPLC)
-
SolubilityDMSO:32 mg/mL (80.72 mM)
-
SMILESCOc1ccc(cc1OCCCC(=O)NO)N(C)c1nc(C)nc2ccccc12
-
Chemical NameButanamide N-hydroxy-4-[2-methoxy-5-[methyl(2-methyl-4-quinazolinyl)amino]phenoxy]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang Z Wang T Wang F et al. Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazolin as the Cap for the Treatment of Cancer[J]. Journal of Medicinal Chemistry 2015 59(4):1455-1470.
molnova catalog
related products
-
Benzenebutyric acid
Benzenebutyric acid is an inhibitor of HDACand is an antineoplastic agent.
-
1-Naphthohydroxamic ...
1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM, and it is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM).
-
Merck60
Merck60 (BRD 6929, Compound-60)is a potent, selective and brain-penetrant inhibitor of HDAC1 and HDAC2 with IC50 of 1 nM and 8 nM respectively.
